RPCEC00000317尚未招募1 期
Application of the CIGB 300 as Antiviral in the treatment of patients with a diagnosis of Covid 19. (COVID-19)
Center for Genetic Engineering and Biotechnology (CIGB), in Havana0 个研究点目标入组 20 人开始时间: 2020年5月28日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled trial. Masking: Open. Control group: Active. Assignment: Parallel. Purpose: Treatment
入排标准
- 年龄范围
- 19 years 至 one（—）
- 性别
- All
入选标准
- •1) Patients who meet the diagnostic criteria for COVID 19 in categories 1 through 4 of the NIH guidelines.
- •2) Age over 18 years.
- •3) Voluntariness of the patient by signing the informed consent.
排除标准
- •1) Pregnancy or lactation at the time of inclusion in the study.
- •2) Patients included in another clinical trial.
- •3) Diseases that compromise the patient's state of consciousness or their possibility of giving their informed consent or collaborating in the trial.
- •4) Critical illness, category 5 of the NIH Guidelines.
研究者
相似试验
招募中
1 期
Phase I/II clinical trial for the evaluation of vaccine candidate CIGB-230 in patients with chronic renal insufficiency.Infection with hepatitis C virus.RPCEC00000098Centro de Ingeniería Genética y Biotecnología (CIGB).60
已完成
1 期
Diphenhydramine previous to CIGB-300 in cervical carcinoma (CERVISEG-II Study)Cervical epidermoid carcinoma, stage IB2-II.RPCEC00000152Center for Genetic Engineering and Biotechnology (CIGB)
尚未招募
2 期
CERVICONC-II-300 studyCervical cancer in stages IB2 and II.Uterine Cervical NeoplasmsUterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasmsUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesRPCEC00000285Center for Genetic Engineering and Biotechnology (CIGB), in Havana144
进行中（未招募）
1 期
Bictegravir concentrations and antiviral activity in cerebrospinal fluid in HIV-1 Infected individualsEUCTR2018-000302-39-ESFundació Lluita contra la SIDA15
进行中（未招募）
1 期
Bictegravir concentrations and antiviral activity in genital fluids and rectal compartment in HIV-1 infected individuals (BIGER Study”).HIV-1 infected male and female adults not previously exposed to ART.EUCTR2018-002310-12-ESFundació Lluita contra la SIDA23